New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2013
21:17 EDTCVD, CRL, NEOG, PRXL, ECL, MMM, BASI, IDXXChina government overhaul includes food and drug safety, WSJ says
China plans to overhaul government agencies including the organizations that oversee its one-child policy and its food and drug safety, says the Wall Street Journal. Reference Link
News For MMM;NEOG;IDXX;ECL;CRL;BASI;PRXL;CVD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2015
08:34 EDTECLEcolab still sees FY15 EPS $4.45-$4.60, consensus $4.52
Subscribe for More Information
08:33 EDTECLEcolab sees Q3 EPS $1.24-$1.31, consensus $1.31
Currency translation and pension are expected to have a combined negative impact of $0.11 per share in the third quarter 2015, or approximately 9% of earnings growth; this compares with a $0.09 per share, or 9%, negative impact in the second quarter 2015.
08:33 EDTECLEcolab reports Q2 EPS $1.08 ex-items, consensus $1.08
Subscribe for More Information
July 27, 2015
07:44 EDTMMM3M pullback a buying opportunity, says BofA/Merrill
BofA/Merrill said the pullback in 3M shares following Q2 results on guidance fears is overdone. The firm said 3M's top line is lees cyclical than peers and shares historically outperform during an industrial slowdown or recession. BofA/Merrill said returns are improving and margins expanding driven by raw material costs and pricing. The firm rates shares a Buy with a $181 price target, down from $190.
July 24, 2015
17:33 EDTPRXLS&P announces changes to S&P 400, 500, and 600 indices
Subscribe for More Information
17:19 EDTPRXLEnanta to replace PAREXEL in S&P 600 as of 7/28 close
17:18 EDTPRXLPAREXEL to replace Signet Jewelers in S&P 400 as of 7/28 close
Subscribe for More Information
09:31 EDTMMM3M weakness a buying opportunity, says Argus
Subscribe for More Information
July 23, 2015
18:21 EDTMMMOn The Fly: Top stock stories for Thursday
Stocks began the session mixed on the heels of weak earnings reports from both Caterpillar (CAT) and 3M (MMM). The Nasdaq managed to spend most of the day in positive territory but joined the other averages in negative territory by mid-afternoon. Selling picked up momentum towards late afternoon, and by day’s end each of the averages were lower by more than 0.4%, with the Dow losing nearly 0.7%. ECONOMIC EVENTS: In the U.S., initial jobless claims fell to 255,000 in the week ended July 18, below the 278,000 first-time claims that were expected. The Leading Economic Indicators advanced 0.6% in June, exceeding expectations for a 0.3% increase. In Asia, the Shanghai Composite index advanced for a sixth straight session, adding another 2.4%. In Europe, the Greek Parliament voted to accept creditor terms for a new bailout, though a decision on when to reopen Greek financial markets was deferred to next week. COMPANY NEWS: Shares of General Motors (GM) finished the session up 3.96% to $31.50 after reporting earnings per share above analyst expectations. Other notable names rising following earnings reports include SanDisk (SNDK), Under Armour (UA), Southwest (LUV)... Caterpillar, meanwhile, dropped $2.86, or 3.59%, to $76.90 after cutting its yearly guidance during this morning's earnings report, with the company noting a "relatively stagnant" global economy. Also lower following earnings were Comcast (CMCSA, CMCSK), Bristol-Myers Squibb (BMY), Dunkin Brands (DNKN), and Boston Scientific (BSX). MAJOR MOVERS: Among the notable gainers was Cigna (CI), which rose $3.29, or 2.18%, to $154.36 after the Wall Street Journal reported last night that Anthem (ANTM) is nearing a deal to acquire the company for roughly $187, representing a total transaction value of over $48B. Adding to that report, CNBC's David Faber said on Thursday morning that Anthem will announce an agreement Friday to purchase Cigna for $188 per share, at a 45% equity, 55% cash split. Also higher were shares of numerous IT security companies, with FireEye (FEYE) advancing 4.53% and Palo Alto Networks (PANW) adding 2.33% after earnings reports from security firms Fortinet (FTNT) and F5 Networks (FFIV) beat on both top and bottom lines. Fortinet and F5, meanwhile, finished Thursday's session up 10.71% and 7.75% to $46.83 and $127.68, respectively. Among the noteworthy losers following earnings was McDonald's (MCD), which edged down 0.52% to $97.10 after noting that Q2 global comparable sales fell 0.7% for the quarter, including a 2% decline in U.S. same-store sales. Also lower was Hertz (HTZ), which declined 8.53% to $16.45 following a downgrade to Underweight at Morgan Stanley, with the research firm citing increased competition from Uber and similar mobility services. INDEXES: The Dow fell 119.12, or 0.67%, to 17,731.92, the Nasdaq lost 25.36, or 0.49%, to 5,146.41, and the S&P 500 declined 12.00, or 0.57%, to 2,102.15.
12:32 EDTMMMOn The Fly: Top stock stories at midday
Subscribe for More Information
10:00 EDTIDXXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:34 EDTIDXXIDEXX upgraded to Hold from Sell at Feltl
Feltl upgraded IDEXX to Hold and increased its price target to $69.50 from $61.50 based on an improved growth outlook and valuation.
07:36 EDTMMM3M narrows FY15 EPS view to $7.80-$8.00 from $7.80-$8.10
Subscribe for More Information
07:33 EDTMMM3M reports Q2 EPS $2.02, consensus $2.00
Subscribe for More Information
July 22, 2015
13:29 EDTMMM3M technical comments before earnings
Subscribe for More Information
July 21, 2015
08:48 EDTNEOGNeogen adversely impacted by currency fluctuations
Subscribe for More Information
08:46 EDTNEOGNeogen reports Q4 EPS 25c, consensus 24c
Subscribe for More Information
July 20, 2015
08:38 EDTIDXXAnalyst predicts Zoetis merges with Bayer unit, not Valeant
Zoetis (ZTS) in recent months has been the subject of takeover speculation, possibly for Valeant (VRX), but a Jefferies analyst told investors today in a research note that he views a deal with a unit of healthcare giant Bayer (BAYRY) as "highly likely" for the animal medicine company. BACKGROUND: Bill Ackman of Pershing Square, who owns stakes in both Zoetis and Valeant, said in early May while speaking on CNBC that Zoetis is a "great” business on a standalone basis, but he also spoke of the company's strategic value. Ackman added, however, that he was "not sure" that Valeant was the best acquirer of Zoetis. Subsequently, in late June, The Wall Street Journal reported that Valeant made a preliminary approach regarding a potential deal to buy Zoetis. CNBC's David Faber said the next day, citing his own sources, that Valeant reached out to Zoetis as a courtesy to common shareholder Ackman and was unlikely to pursue an acquisition of the company, though he cautioned then Valeant could change its approach and pursue a deal. BAYER: Jefferies analyst Jeffrey Holford said in a note today that he views a tie-up between Zoetis and Bayer's Animal Health business in 2016 as "highly likely." He sees Mylan's (MYL) acquisition of Abbott's (ABT) non‑U.S. developed markets specialty and branded generics business as a potential proxy for how a transaction could be structured, adding that such a "spinversion" could achieve up to 36% long-term earnings accretion for Zoetis. Holford reiterated a Buy rating on Zoetis with a $60 price target, while downgrading Bayer to Hold, citing valuation following the recent outperformance of its shares. IDEXX: While being discussed as a target, some analysts have also opined on companies that Zoetis could pursue as a buyer. On June 29, Canaccord said that in investor meetings with IDEXX (IDXX) executives declined to comment on Zoetis' potential interest in scaling up its animal health diagnostics business. Canaccord added that it thought Zoetis could make a bid for IDEXX. The firm reiterated its Buy rating and $80 price target on IDEXX shares at that time. PRICE ACTION: Since June 25, the day the Journal first reported on Valeant's preliminary takeover approach to Zoetis, the animal health company's shares have dropped nearly 4%. Zoetis closed down 20c to $47.80 on Friday.
July 15, 2015
09:41 EDTIDXXIDEXX should be watched after 'curious' board change, dealReporter says
IDEXX Laboratories (IDXX), which analysts have previously speculated could be a takeover target for Zoetis (ZTS), should be watched for any possible M&A hints after the "curious addition" of Advanced Micro Devices (AMD) Chairman Bruce Claflin to its board yesterday, said dealReporter, according to contacts.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use